Presentations – 13th INTEREST

Tuesday 14 MayWednesday 15 MayThursday 16 MayFriday 17 May

Tuesday 14 May

  Session 1 - Official Opening session 

The Road to 90-90-90: Progress in HIV Prevention and Treatment Scale-up in Sub-Saharan Africa
Karusa Kiragu, PhD
UNAIDS, Uganda


Current Status of HIV in Ghana
Kyeremeh Atuahene
Ghana AIDS Commission, Ghana


Community Perspective on Progress in Ghana
Cecilia Senoo
Hope for Future Generation, Ghana

 Session 2 - HIV Prevention: Who’s in, Who’s out and Who’s Shaking It All About?

Evolving Use of Oral PrEP (Lessons Learned) and Update on New Prevention Technologies – Rings, Long-acting Injectables, Implants
Sinead Delany-Moretlwe, MBBCh, PhD, DTM&H
The Wits Reproductive Health and HIV Institute (WRHI), University of the Witwatersrand, South Africa


What about the Men: Finding the Missing Connection
Daniel Were, PhD
Jhpiego, Kenya

 Oral Abstract-driven Presentations I
No videos are published for abstract-driven presentations

High Rate of PrEP Eligibility and Associated HIV Incidence in a Generalized Epidemic
Victor Ssempijja

 Dually Enacted Stigma among Young People and their Caregivers Living with HIV: Challenges and Opportunities to Reaching 90-90-90 in Zambia
Joseph Gregory Rosen

 Implementing a National Mhealth System Improves Viral Suppression and Retention in Routine HIV Care in Kenya
Anthony Wachira
 Increasing Access to Antiretroviral Therapy; Lessons Learnt from Implementing Family Centered PMTCT Option B+ Services in 13 States in Nigeria
Ihoghosa Iyamu
 Session 3 - Innovative Work with Key Populations in Africa

Progress in Engaging Key Populations in Africa
Christopher Akolo, MD, MSc, FWACP

 Session 4 - Update on Hormonal Contraception and HIV Risk

Why the ECHO Trial and What Will It Tell Us?
Elizabeth Bukusi, MBChB, MMed, MPH, PhD, PGD, MBE
Kenya Medical Research Institute, Kenya

 Session 5 - Community Impact of Treatment

PopART in Zambia and South Africa: What Have We Learned?
Albertus Schaap, MSc
London School of Hygiene and Tropical Medicine / Zambart, United Kingdom / Zambia

 Session 6 - Opening Day Formal Debate: The “U=U” Message is Not Appropriate for Africa
 First Speaker for the Proposition
François Venter, MBCCH, MMed, FCP, DTM&H, Dip HIV Man
University of the Witwatersrand, South Africa
 First Speaker against the Proposition
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Desmond Tutu HIV Foundation, South Africa
 Second Speaker for the Proposition
(Not yet available)

Tapiwanashe Kujinga, LLB
Pan-African Treatment Access Movement, Zimbabwe
 Second Speaker against the Proposition
(Not yet available)

Lucy Wanjiku Njenga
Positive Young Women Voices, Kenya

Wednesday 15 May

 Session 7 - Update on HIV Vaccines and the Promise of a Cure

HIV Vaccine Pipeline and Progress, Including Broadly Neutralizing Antibodies (BnAbs)
Glenda Gray, MBBCh, FCPaed(SA), DSc (Hons)
South African Medical Research Council, South Africa

 Acute Infection and HIV Cure: Current Status and Implications for the Future
(No permission given for slides or video publication)

Zaza Ndhlovu, PhD
Africa Health Institute, SA/Zimbabwe
 Oral Abstract-driven Presentations II
No videos are published for abstract-driven presentations
 Association Between Contraceptive Use and PrEP Uptake and Continuation in Adolescent Girls and Young Women in Cape Town, South Africa
Elzette Rousseau
 The Role of Executive Functioning in Medical Adherence: Evidence from the HIV Associated Neuro-Cognitive Disorders Study in Zambia
Sylvia Mwanza-Kabaghe
 Sexually Transmitted Infections in MSM in West Africa: Incidence and Associated Factors (CohMSM ANRS 12324–Expertise France)
Issifou Yaya
 Alcohol Use, Aggressive Behaviours and Mental Health Status are Associated with All Identified Typologies of Risky Sexual Behaviours Among Adolescent Girls and Young Women (10-24 years) in Western Cape, South Africa
Joel Francis
 SYMPOSIUM I - Gilead: Viral Hepatitis C in Africa: Working Towards Elimination Goals
 Introduction: Objective and Goals Viral Hepatitis and Elimination Efforts Overview, African Perspective, WHO Goals, and Introduction to Elimination
(Not yet available)

Mark Sonderup
University of Cape Town, South Africa
 Overview of Viral Hepatitis Elimination Efforts in Rwanda - Success Factors and Challenges
(Not yet available)

Emmanuel Musabeyezu
King Faisal Hospital, Rwanda
 Overview of Viral Hepatitis Elimination Efforts in Egypt - Success Factors and Challenges
(Not yet available)

Imam Waked
Menoufiya University, Egypt
 Viral Hepatitis Landscape in South Africa and Implementation Plans
(Not yet available)

Mark Sonderup
University of Cape Town, South Africa
 Mini-Oral Abstract Presentations I
No videos are published for abstract-driven presentations
 Male Engagement Optimization in Antenatal Care Clinics to Assess Need for Pre-Exposure Prophylaxis in Serodiscordant Couples: Estimation Based on Preliminary Data from a Cluster Randomized Trial in Zambézia Province, Mozambique
Caroline De Schacht
 Healthcare Providers’ Attitudes and Experiences Delivering Oral PrEP to Adolescent Girls and Young Women: Implementation Research to Inform PrEP Rollout in Kenya, South Africa, and Zimbabwe
Definate Nhamo
 Continuity of PrEP Use and Reasons for Discontinuation: A Cohort Study in a General Eswatini Population
(No permission for publication)

Shreoshee Mukherjee
 PrEP Uptake and Various Referral Channels in Kenya: Cross-Sectional Analysis of a Large Scale Program
Micah Anyona
 Shifts in HIV Risk Outcomes among Adolescent Girls and Young Women (AGYW): Mixed Effects of DREAMS Interventions in Kenya
Jerry Okoth Okal
 SYMPOSIUM II - Johnson & Johnson: Optimising Treatment for Life-long Management of HIV

This symposium was held by the following speakers:

Kwasi Torpey
University of Ghana College of Health Sciences, Ghana

Fafa Addo Boateng
Johnson & Johnson Global Public Health Africa

Michelle Moorhouse
University of Witwatersrand / Charlotte Maxeke Academic Hospital, South Africa

Lloyd Mulenga
University Teaching Hospital / University of Zambia School of Medicine, Zambia

 SYMPOSIUM III - Joep Lange Institute: Winners for Africa

Welcome and Introduction
Tobias Rinke de Wit
Joep Lange Institute, The Netherlands


Using Single Cell RNAseq to Unravel Unconventional T-cell Responses
Shaheed Abdulhaqq
Oregon Health and Science University, Vaccine and Gene Therapy Institute, United States


Immune Activation and Depression in HIV Infection
Jonathan Chang
Duke University School of Medicine, United States


Epidemiology and Control of STIs in the Era of PrEP
Michael Traeger
Burnet Institute, Australia


Towards an HIV Risk Profile for Zambian Female Sex Workers
Kalonde Malama
Aix-Marseille University, France


Embracing Innovation in HIV Pediatric Diagnostics: A Win for Africa
Francis Matthew Simmonds
Elizabeth Glaser Pediatric AIDS Foundation, Zimbabwe

 Session 8 - Emerging and Re-emerging Pathogens

Research Preparedness for Viral Haemorrhagic Fevers in West Africa: The Lassa Fever Example
Adebola Olayinka, MD, PhD
Nigeria Centre for Disease Control, Nigeria


Thursday 16 May

 Session 9 - Treatment

HIV Drug Resistance
Raquel Viana, PhD
Molecular Pathology Department for Lancet oratories, South Africa


Treatment Strategies from a Public Health Perspective
Meg Doherty, MD, MPH, PhD
World Health Organisation, Switzerland

 Mini Oral Abstract-driven Presentations II
No videos are published for abstract-driven presentations
 Treatment Outcome among Patients on ART in Southern Tanzania: Does Time of ART Initiation Matter?
Bernadeta Msongole
 Pregnancy and Infant Outcomes among HIV-positive Women on Dolutegravir Versus Efavirenz-based Antiretroviral Therapy: Week 48 Analysis of the ADVANCE Trial
Nomathemba Chandiwana
 HIV Multi-class Resistance in Patients Failing to First and Second-Line ART in Resources Limited Setting, Mali
Almoustapha Issiaka Maiga
 Can Genotyping after Second-line ART Failure Reduce the Need for DRV/r-Based Third-Line ART in Kenya?
Dorothy Mwagae
 Self-reported HIV-positive Status but Subsequent HIV-negative Test Results in Population-Based HIV Impact Assessment (PHIA) Survey Participants – 11 Sub-Saharan African Countries, 2015-2017
Naeemah Logan
 SYMPOSIUM IV: ViiV - Scientific Debate: 2DR is the Next Frontier in HIV Treatment

(Not yet available)

Joseph Oliver-Commey

Ghana Health Service, Ghana

Michelle Moorhouse
University of Witwatersrand / Charlotte Maxeke Academic Hospital, South Africa

Francois Venter
University of Witwatersrand, South Africa

Frank Post
King’s College Hospital NHS Foundation Trust, United Kingdom

 SYMPOSIUM V: Abbvie: Journey towards Bridging the Gap in Monitoring HIV Viral Load in Resource-Limited Settings: The Third 90 Experiences in Kenya, Nigeria, and Zambia.

Opening Remarks and Introduction of Speakers
David Kalombo
Foundation for Professional Development, South Africa

 The Third 90 Experiences in Zambia
(Not yet available)

Lloyd Mulenga
Ministry of Health, Zambia
 The Third 90 Experiences in Kenya
(Not yet available)

Maureen Kimani
National AIDS & STI Control Programme, Kenya

The Third 90 Experiences in Nigeria
Hadiza Khamofu
FHI360, Nigeria

 Mini Oral Abstract-driven Presentations III
No videos are published for abstract-driven presentations
 Addressing Barriers to Effective Scale Up of Viral Load Uptake: the Case of Viral Load Sample Rejection Rates in Five Counties in Kenya
Romeo Kithuka
 Effect of Strategic Index Case Testing on HIV Case Detection in Nigeria: APIN Experience
Scott Adamu
 Reaching the Unreachable: Early Results from Index Testing in Zambia in the CIRKUITS Project
Linah K. Mwango
 Maximizing HIV Testing Yield Through Index Partner Testing Using Assisted Partner Notification (APN) Approach: Implementation Progress in Uganda
John Bosco Junior Matovu
 Partner Delivered HIV Self-Testing is Highly Acceptable and Facilitates Linkage to Care for Partners of HIV Index and Antenatal Care Clients in South Africa
Vincent Zishiri
 Session 10 - Laboratory Science at the Service of the Response

Laboratory QA and Innovation
Pascale Ondoa, MD, MSc, PhD
African Society of Laboratory Medicine, The Netherlands

 SYMPOSIUM VI: International AIDS Society (IAS): Differentiated Service Delivery in West and Central Africa – From Pilots to Policy.

Providing Community ART in a Time of Conflict: Pilot Projects from Central African Republic
Charles Ssonko
Médecins Sans Frontières, United Kingdom


Patient Preference: Scaling up PODIs, Fast-track, and ART Refills in Peer Support Groups in the Democratic Republic of the Congo
Didier Kamerhe
PATH, Democratic Republic of the Congo


Pushing ART Refills to Six Months: National Policy Progress in Guinea
Foromo Guilavogui
Ministry of Health, Guinea


Putting the Policy into Practice: The Experience of DSD Guidance in Ghana
Nyonuku Akosua Baddoo
Ministry of Health, Ghana

 Mini Oral Abstract-driven Presentations IV
No videos are published for abstract-driven presentations
 Improved Case Detection and Management of Advanced HIV Disease through TB Contact Risk Stratification and Implementation of a Package of Interventions in a Rural District of Mozambique
Santiago Izco
 “From Ostracism to Centralism” The Evolution of Meaningful Involvement of People Living with HIV (MIPA) in Zimbabwe Resulting in Improved Health Outcomes
Silibele Mpofu
 Évaluation de l’Efficacité Virologique et Clinique de la Prise en Charge Thérapeutiques des Enfants VIH+ dans les Régions Sud du Sénégal (EnPRISE2)
Aminata Niang
 Mortality and Virologic Outcomes between Two to Five Years of Age after Early Initiation during Infancy of Antiretroviral Treatment: Experience of the ANRS-1240 Pediacam Study (Cameroon)
Francis Ateba Ndongo
 Point-of-Care Early Infant Diagnostic Testing at Alternative Entry Points: a High-Yield, Cost-Efficient Strategy to Increase HIV Positive Infant Case Finding
Isaac Ssewanyana
 Session 11 - Paediatrics: Leaving No One Behind

Stepping on the Accelerator: Innovations in Pediatric HIV Programming
Nadia A. Sam-Agudu, MD, CTropMed
Institute of Human Virology/ University of Maryland School of Medicine, Nigeria / USA

 Session 12 - Non-Communicable Disease

Burden of Disease, Prevention Strategies, Treatment Studies, Service Intergration
Gerald Yonga, MBChB, MMed, FRCP, MBA, FESC, FACC
Aga Khan University Hospital, Kenya

 Session 13 - Women in Science, Medicine, and Global Health

Advancing Women: What Do We Need to Do and How?
(No video available)
Helen Rees, MD, MA, MRCGP
The WITS Reproductive Health and HIV Institute (WRHI), University of the Witwatersrand, South Africa



Friday 17 May

 Mini Oral Abstract-driven Presentations V
No videos are published for abstract-driven presentations
 Examining the Effectiveness of Differentiated Service Delivery Models for HIV Testing among Female Sex Workers in Ghana
David Tetteh Nartey
 Sexual and Mental Health of Transgender Persons in Nairobi, Kenya
Rodah Wanjiru
 Analyse Coût-Efficacité d’une Stratégie Thérapeutique à Base de Sofosbuvir dans le Traitement de l’Hépatite C en Afrique Centrale et de l’Ouest (ANRS 12311)
Maël Baudoin
 Improved HIV Testing Efficiency in Zambia through Enhanced Real-time Program Surveillance
Andres Montaner
 Reasons for PrEP Decline among Clients Identified at Substantial Risk for HIV Infection in the Kingdom of Eswatini
Sindy Matse
 Session 14 - Update on Tuberculosis
 State of the Response, New Drugs and Diagnostics, Vaccine Developments, Advocacy, and Lessons Learned from UN General Assembly on TB
Kogieleum Naidoo, MBChB, PhD
Centre for the AIDS Programme of Research in South Africa, South Africa
 SYMPOSIUM VII: Roche - Debate: Patient Self- Management - Radical patient self-management will address current health challenges in Africa
An engaging debate bringing together scientists from the African continent

(Slides and videos not yet available)

Francois Venter
University of Witwatersrand, South Africa

Sergio Carmona
Charlotte Maxeke Academic Hospital, South Africa

Sindisiwe Van Zyl
Private Practice, South Africa

Tendani Gaolathe
Ministry of Health, Botswana

 Session 15 - Science in Action
 The Importance of Science and Innovation for the Global Fund
Christoph Benn
Global Fund, Switzerland
 Session 16 - Ethics of Choice in Public Sector Programmes, Including Access to Contraception
 Three Billboards on West African Adolescent HIV Prevention Studies: Rights, Complexities and Possible Solutions
Ann Strode, BA, LLB, LLM, PhD
University of KwaZulu-Natal, South Africa
 Mini Oral Abstract-driven Presentations VI
No videos are published for abstract-driven presentations
 Factors Associated with Liver Injury among HIV Infected Children and Adolescents Attending a National Referral Pediatric HIV Clinic in Uganda
Bonny Mulindwa
 Prevalence of Cervical HPV Infection among Women Living with HIV in Harare, Zimbabwe
Ardele Maureen Mandiriri
 Application of Machine Learning Models in Prediction of PrEP Retention among High-risk Persons in Uganda
Agnes Kiragga
 Economic Burden of Accessing Treatment on People Living with HIV; Outcomes of a Cross-Sectional Survey in Lagos State, Nigeria
Adewale Ogunnaike
 Characterizing the HIV Epidemic among 15-24 Year Olds in Urban Ethiopia, 2017-18
Aderonke Ajiboye
 Session 17 - Closing Session
 Presentation of the Joep Lange Award to Highest Scoring Abstract by an Early-Career African Scientist
(No slides available)